Clinical Trial Update: Serplulimab+Regorafenib +Hepatic Artery Bicarbonate Infusion in Patients With Colorectal Cancer and Liver Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating serplulimab combined with regorafenib and hepatic artery bicarbonate infusion for colorectal cancer with liver metastases; c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• Regorafenib (regorafenib)
• Serplulimab (serplulimab)
• hepatic artery bicarbonate infusion

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Colorectal Cancer, Liver Metastases | Phase 2 | Status: UNKNOWN